RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > EMA-FDA Joint GMP and GCP Inspection Pilot Programs

EMA-FDA Joint GMP and GCP Inspection Pilot Programs

Posted 01 October 2011 | By Michelle Conan-Cibotti, PhD, RAC

The global harmonization of regulatory requirements for the registration of pharmaceutical products started in the 1990s with the International Conference on Harmonisation (ICH). Ensuring consistent interpretation and implementation of ICH guidelines and continuous delivery of safe and effective products to consumers remains a challenge for regulators and industries.


© 2022 Regulatory Affairs Professionals Society.